SWOG clinical trial number
SWOG-9127
Evaluation of Cisplatin, Carboplatin and Etoposide in Selected Stage IIIb and Stage IV Non-Small Cell Lung Carcinoma, Phase II
Closed
Phase
Accrual
100%
Published
Abbreviated Title
Evaluation of Cisplatin, Carboplatin and Etoposide in Selected Stage IIIb and Stage IV Non-Small Cell Lung Carcinoma, Phase II
Activated
08/01/1991
Closed
03/01/1992
Research committees
Lung Cancer
Publication Information Expand/Collapse
1996
Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma: A phase II study of the Southwest Oncology Group.
Other Clinical Trials
SWOG Clinical Trial Number
CTSU/EA5231
A Randomized Phase III Trial of Checkpoint Blockade in Lung Cance3r Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)
Research Committee(s)
Lung Cancer
Activated
06/13/2025
Open
SWOG Clinical Trial Number
S2414
INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)
Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
CTSU/A082304/S2402
Perioperative Versus Adjuvant Systemic Therapy In Patients with Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG, CTIU2317
Research Committee(s)
Lung Cancer
Activated
12/11/2024
Open